NASDAQ:ELVN | EBITDA | Enliven Therapeutics, Inc.

Complete source-backed ebitda history.

Available history
2022-03-31 to 2026-06-30
Data captured

Historical EBITDA

DateEBITDA
2026-06-30-$37.2M
2026-03-31-$27.81M
2025-12-31-$34.2M
2025-09-30-$25.03M
2025-06-30-$28.5M
2025-03-31-$31.62M
2024-12-31-$26.83M
2024-09-30-$26.99M
2024-06-30-$24.52M
2024-03-31-$25.91M
2023-12-31-$22.65M
2023-09-30-$24.17M
2023-06-30-$20.06M
2023-03-31-$16.35M
2022-12-31-$10.11M
2022-09-30-$10.87M
2022-06-30-$8.96M
2022-03-31$30.32M

Annual EBITDA

DateEBITDA
2025-12-31-$119.36M
2024-12-31-$104.25M
2023-12-31-$83.23M
2022-12-31-$38.59M